Product Images Doxazosin Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Doxazosin Mesylate NDC 53808-1017 by State Of Florida Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text is a table containing different studies on the effectiveness of CARDURA in placebo-controlled trials. These studies analyzed the change in symptom score, modified Bojarsky questionnaire change, and maximum flow rate in patients with BPH. The results show that CARDURA was more effective than a placebo in reducing symptoms and improving the maximum flow rate. The text also includes statistical data, such as the mean, baseline, and standard deviation.*
This is a chart that shows the mean change in total symptoms score and mean increase in maximum urinary flow rate (measured in mUsec) from baseline in a group of 50 patients taking CARDURA. The chart shows the change over a treatment duration of up to 12 weeks, with doxazosin titration to a maximum of 8 mg. There are statistical significance indicators shown for comparisons between treatment groups and baseline.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.